He Kaichuan, Zhang Huaxing, Tan Bo, Song Chengqing, Liang Zihui, Zhang Lixia, Tian Danyang, Xiao Lin, Xue Hongmei, Guo Qi, Teng Xu, Jin Sheng, An Cuixia, Wu Yuming
Department of Physiology, Hebei Medical University, 050017, Hebei, China.
Core Facilities and Centers, Hebei Medical University, 050017, Hebei, China.
Cardiovasc Drugs Ther. 2024 Jun 17. doi: 10.1007/s10557-024-07586-w.
Aging contributes significantly to cardiovascular diseases and cardiac dysfunction, leading to the upregulation of matrix metalloproteinase-9 (MMP-9) in the heart and a significant decrease in hydrogen sulfide (HS) content, coupled with impaired cardiac diastolic function. This study explores whether supplementing exogenous hydrogen sulfide during aging ameliorates the decline in HS concentration in the heart, suppresses MMP-9 expression, and improves the age-associated impairment in cardiac morphology and function.
We collected plasma from healthy individuals of different ages to determine the relationship between aging and HS and MMP-9 levels through Elisa detection and liquid chromatography-tandem mass spectrometry (LC/MC) detection of plasma HS content. Three-month-old mice were selected as the young group, while 18-month-old mice were selected as the old group, and sodium hydrosulfide (NaHS) was injected intraperitoneally from 15 months old until 18 months old as the old + NaHS group. Plasma MMP-9 content was detected using Elisa, plasma HS content, cardiac HS content, and cystathionine gamma-lyase (CSE) activity were detected using LC/MC, and cardiac function was detected using echocardiography. Heart structure was assessed using hematoxylin and eosin staining, Masone staining was used to detect the degree of cardiac fibrosis, while western blot was used to detect the expression of MMP-9, CSE, and aging marker proteins. Knockdown of MMP-9 and CSE in H9c2 cells using small interfering RNA was carried out to determine the upstream-downstream relationship between MMP-9 and CSE.
HS content in the plasma of healthy individuals decreases with escalating age, whereas MMP-9 level rises with age progression. Aging leads to a decrease in HS levels in the heart and plasma of mice, severe impairment of cardiac diastolic function, interstitial relaxation, and fibrosis of the heart. Supplementing with exogenous HS can improve these phenomena.
HS maintains the structure and function of the heart by inhibiting the expression of MMP-9 during the aging process.
衰老对心血管疾病和心脏功能障碍有显著影响,导致心脏中基质金属蛋白酶-9(MMP-9)上调,硫化氢(HS)含量显著降低,同时心脏舒张功能受损。本研究探讨衰老过程中补充外源性硫化氢是否能改善心脏中HS浓度的下降,抑制MMP-9表达,并改善与年龄相关的心形态和功能损害。
我们收集不同年龄健康个体的血浆,通过酶联免疫吸附测定(ELISA)检测及液相色谱-串联质谱(LC/MC)检测血浆HS含量,以确定衰老与HS及MMP-9水平之间的关系。选取3个月大的小鼠作为年轻组,18个月大的小鼠作为老年组,从15个月大至18个月大对老年组小鼠腹腔注射氢硫化钠(NaHS)作为老年+NaHS组。采用ELISA检测血浆MMP-9含量,用LC/MC检测血浆HS含量、心脏HS含量及胱硫醚γ-裂解酶(CSE)活性,用超声心动图检测心脏功能。用苏木精-伊红染色评估心脏结构,用马松染色检测心脏纤维化程度,用蛋白质免疫印迹法检测MMP-9、CSE及衰老标志物蛋白的表达。利用小干扰RNA敲低H9c2细胞中的MMP-9和CSE,以确定MMP-9与CSE之间的上下游关系。
健康个体血浆中的HS含量随年龄增长而降低,而MMP-9水平随年龄增长而升高。衰老导致小鼠心脏和血浆中的HS水平降低,心脏舒张功能严重受损,心肌间质松弛和纤维化。补充外源性HS可改善这些现象。
在衰老过程中,HS通过抑制MMP-9的表达维持心脏的结构和功能。